List of life saving transplantations

The ultimate goal of our service is to use stored stem cells for transplantations. For this reason we are proud to have been by our customers’ side time and time again during difficult circumstances by collecting, storing and preparing life-saving biological material for transplantation.

Filter by

No. Cell source Indication Area of medicine Year Type of therapy Country Recipient age
1 autologous cord blood cerebral palsy neurology 2017 experimental therapy Poland 2.2
2 autologous cord blood cerebral palsy neurology 2017 experimental therapy Poland 5.4
3 autologous cord blood cerebral palsy neurology 2017 experimental therapy Poland 10.3
4 autologous cord blood autism neurology 2017 experimental therapy Poland 4.11
5 autologous cord blood cerebral palsy neurology 2017 experimental therapy Poland 6.8
6 autologous cord blood autism neurology 2017 experimental therapy Poland 6.2
7 autologous cord blood autism neurology 2016 experimental therapy Poland 6
8 autologous cord blood cerebral ischemia neurology 2008 experimental therapy Poland 1.5
9 cord blood CD40 ligand deficiency hematology 2017 standard therapy Turkey 9.6
10 cord blood talassemia major hematology 2017 standard therapy Turkey 4.0
11 cord blood talassemia major hematology 2017 standard therapy Turkey 4.1
12 cord blood relapse of acute lymphoblastic leukemia hematology 2017 standard therapy Poland 7.3
13 cord blood acute myeloid leukemia hematology 2016 standard therapy Jordan 6
14 cord blood acute lymphoblastic leukemia hematology 2016 standard therapy Hungary 7
15 cord blood acute lymphoblastic leukemia hematology 2015 standard therapy Poland 4
16 cord blood acute lymphoblastic leukemia hematology 2014 standard therapy Turkey 7
17 cord blood aplastic anaemia hematology 2013 standard therapy Poland 3
18 cord blood acute myeloid leukemia hematology 2013 standard therapy Poland 3
19 cord blood beta-talassemia; agranulocytosis hematology 2013 standard therapy Turkey 8
20 cord blood X - linked lymphoproliferative syndrome hematology 2013 standard therapy Poland 10.12
21 cord blood severe aplastic anaemia hematology 2012 standard therapy Hungary 3
22 cord blood anaemia, talassemia major hematology 2012 standard therapy Turkey 6
23 cord blood talassemia major, acute lymphoblastic leukemia hematology 2012 standard therapy Turkey 3.5
24 cord blood T-acute lymphoblastic leukemia hematology 2012 standard therapy Turkey 5
25 cord blood Fanconi anemia hematology 2011 standard therapy Poland 12
26 cord blood acute myeloid leukemia hematology 2011 standard therapy Hungary 2
27 cord blood acute lymphoblastic leukemia hematology 2011 standard therapy Poland 5
28 cord blood histiocytosis hematology 2011 standard therapy Poland 2.5
29 cord blood chronic granulomatous disease hematology 2011 standard therapy Poland 7.5
30 cord blood pre -B acute lymphoblastic leukemia hematology 2010 standard therapy Hungary 1.5
31 cord blood myelodysplastic syndrome hematology 2009 standard therapy Poland 5
32 cord blood acute lymphoblastic leukemia hematology 2008 standard therapy Poland 5
33 cord blood neuroblastoma hematology 2007 standard therapy Poland 8
34 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 2.10
35 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 67.11
36 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 37.9
37 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 71.7
38 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland no data
39 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 7.11
40 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 47.6
41 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2017 experimental therapy Poland 44.1
42 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2017 experimental therapy Poland 34.11
43 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 58.10
44 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 49.0
45 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2017 experimental therapy Poland 37.4
46 cord tissue (Wharton's jelly) muscular dystrophy neurology 2017 experimental therapy Poland 37.7
47 cord tissue (Wharton's jelly) muscular dystrophy neurology 2017 experimental therapy Poland 26.11
48 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 56.7
49 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 48.11
50 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 46.3
51 cord tissue (Wharton's jelly) cartilage damage orthopedics 2017 experimental therapy Poland 61.5
52 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2017 experimental therapy Poland 34.1
53 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2017 experimental therapy Poland 52.9
54 cord tissue (Wharton's jelly) atrophy of the optic nerves ophthalmology 2017 experimental therapy Poland 23.9
55 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2017 experimental therapy Poland 31.6
56 cord tissue (Wharton's jelly) age-related macular degeneration ophthalmology 2017 experimental therapy Poland 33.4
57 cord tissue (Wharton's jelly) tetraparesis spastica neurology 2017 experimental therapy Poland 29.4
58 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2017 experimental therapy Poland 24.9
59 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2017 experimental therapy Poland 10.6
60 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2017 experimental therapy Poland 30.0
61 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 56.8
62 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 65.2
63 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 45.9
64 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /DMD neurology 2017 experimental therapy Poland 28.6
65 cord tissue (Wharton's jelly) limb-girdle muscular dystrophy neurology 2017 experimental therapy Poland 44.2
66 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2017 experimental therapy Poland 41.4
67 cord tissue (Wharton's jelly) limb-girdle muscular dystrophy neurology 2017 experimental therapy Poland 25.8
68 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 75.9
69 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2017 experimental therapy Poland 23.7
70 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 43.4
71 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2017 experimental therapy Poland 39.0
72 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 51.3
73 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2017 experimental therapy Poland 39.0
74 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 42.11
75 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2017 experimental therapy Poland 30.9
76 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2017 experimental therapy Poland 12.11
77 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2017 experimental therapy Poland 8.5
78 cord tissue (Wharton's jelly) gonarthrosis orthopedics 2017 experimental therapy Poland 58.9
79 cord tissue (Wharton's jelly) cri du chat syndrome neurology 2017 experimental therapy Poland 8.6
80 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 18.7
81 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 59.8
82 cord tissue (Wharton's jelly) muscular dystrophy neurology 2017 experimental therapy Poland 22.1
83 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /DMD neurology 2017 experimental therapy Poland 28.11
84 cord tissue (Wharton's jelly) epilepsia neurology 2017 experimental therapy Poland 3.1
85 cord tissue (Wharton's jelly) cranium bifidum neurology 2017 experimental therapy Poland 5.2
86 cord tissue (Wharton's jelly) transverse myelitis neurology 2017 experimental therapy Poland 8.3
87 cord tissue (Wharton's jelly) syringomielia neurology 2017 experimental therapy Poland 42.6
88 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 64.9
89 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2017 experimental therapy Poland 47.2
90 cord tissue (Wharton's jelly) limb-girdle muscular dystrophy neurology 2017 experimental therapy Poland 38.5
91 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 56.7
92 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 13.4
93 cord tissue (Wharton's jelly) encephalopathy neurology 2017 experimental therapy Poland 21.10
94 cord tissue (Wharton's jelly) encephalopathy neurology 2017 experimental therapy Poland 5.0
95 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 41.0
96 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 52.1
97 cord tissue (Wharton's jelly) cerebral palsy; neonatal cerebral leukomalacia neurology 2017 experimental therapy Poland 1.9
98 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 11.11
99 cord tissue (Wharton's jelly) limb-girdle muscular dystrophy neurology 2017 experimental therapy Poland 26.10
100 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 9.1
101 cord tissue (Wharton's jelly) cerebellar syndrome neurology 2017 experimental therapy Poland 11.5
102 cord tissue (Wharton's jelly) congenital fiber-type disproportion myopathy neurology 2017 experimental therapy Poland 1.10
103 cord tissue (Wharton's jelly) chronic myeloid leukemia hematology 2017 experimental therapy Poland 5.11
104 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 61.5
105 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 40.11
106 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 48.1
107 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 1.11
108 cord tissue (Wharton's jelly) muscular dystrophy neurology 2017 experimental therapy Poland 37.11
109 cord tissue (Wharton's jelly) arthrogryposis multiplex congenita neurology 2017 experimental therapy Poland 1.7
110 cord tissue (Wharton's jelly) encephalopathy; cerebral palsy neurology 2017 experimental therapy Poland 4.4
111 cord tissue (Wharton's jelly) cerebral palsy; epilepsy neurology 2017 experimental therapy Poland 5.8
112 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2017 experimental therapy Poland 6.4
113 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 15.4
114 cord tissue (Wharton's jelly) traumatic brain injury neurology 2017 experimental therapy Poland 9.4
115 cord tissue (Wharton's jelly) no bone adhesion orthopedics 2017 experimental therapy Poland 14.1
116 cord tissue (Wharton's jelly) no bone adhesion orthopedics 2017 experimental therapy Poland 17.11
117 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 69.10
118 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2017 experimental therapy Poland 24.9
119 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2017 experimental therapy Poland 37.7
120 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 31.1
121 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 52.11
122 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2017 experimental therapy Poland 27.11
123 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2017 experimental therapy Poland 45.4
124 cord tissue (Wharton's jelly) muscular dystrophy neurology 2017 experimental therapy Poland 34.10
125 cord tissue (Wharton's jelly) muscular dystrophy neurology 2017 experimental therapy Poland 31.6
126 cord tissue (Wharton's jelly) hydrocephalus; neonatal cerebral leukomalacia neurology 2017 experimental therapy Poland 2.3
127 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 6.3
128 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 7.11
129 cord tissue (Wharton's jelly) delayed psychomotor development neurology 2017 experimental therapy Poland 3.5
130 cord tissue (Wharton's jelly) delayed psychomotor development neurology 2017 experimental therapy Poland 6.3
131 cord tissue (Wharton's jelly) syndrom IFAP hematology 2017 experimental therapy Poland 3.5
132 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 52.0
133 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2017 experimental therapy Poland 13.0
134 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2017 experimental therapy Poland 11.10
135 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2017 experimental therapy Poland 66.11
136 cord tissue (Wharton's jelly) ischemia within the optic nerve ophthalmology 2017 experimental therapy Poland 37.11
137 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 35.1
138 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 4.11
139 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 77.2
140 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 36.11
141 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 63.11
142 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 35.6
143 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 31.9
144 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 31.9
145 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 10.2
146 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 33.5
147 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 5.7
148 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 12.5
149 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 5.9
150 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 3.3
151 cord tissue (Wharton's jelly) delayed psychomotor development neurology 2017 experimental therapy Poland 5.0
152 cord tissue (Wharton's jelly) hypoxia-ischemic encephalopathy neurology 2017 experimental therapy Poland 1.9
153 cord tissue (Wharton's jelly) Krabbe disease neurology 2017 experimental therapy Poland 6.3
154 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2017 experimental therapy Poland 24.6
155 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 51.6
156 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 45.5
157 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2017 experimental therapy Poland 31.5
158 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2017 experimental therapy Poland 48.10
159 cord tissue (Wharton's jelly) muscular dystrophy neurology 2017 experimental therapy Poland 62.5
160 cord tissue (Wharton's jelly) cerebellar syndrome neurology 2017 experimental therapy Poland 60.5
161 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 6.1
162 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 4.8
163 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 6.4
164 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 6.3
165 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 46.0
166 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 49.1
167 cord tissue (Wharton's jelly) condition after encephalitis neurology 2017 experimental therapy Poland 19.7
168 cord tissue (Wharton's jelly) muscular dystrophy neurology 2017 experimental therapy Poland 35.4
169 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 1.10
170 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 6.8
171 cord tissue (Wharton's jelly) encephalopathy; cerebral palsy neurology 2017 experimental therapy Poland 1.5
172 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 7.0
173 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 13.6
174 cord tissue (Wharton's jelly) muscular dystrophy neurology 2017 experimental therapy Poland 6.7
175 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2017 experimental therapy Poland 32.3
176 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2017 experimental therapy Poland 46.9
177 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 54.10
178 cord tissue (Wharton's jelly) dystrophia myotonica neurology 2017 experimental therapy Poland 41.11
179 cord tissue (Wharton's jelly) global developmental delay neurology 2017 experimental therapy Poland 4.7
180 cord tissue (Wharton's jelly) optic neuropathy ophthalmology 2017 experimental therapy Poland 56.4
181 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 4.1
182 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 3.6
183 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2017 experimental therapy Poland 33.4
184 cord tissue (Wharton's jelly) muscular dystrophy neurology 2017 experimental therapy Poland 42.1
185 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2017 experimental therapy Poland 2.4
186 cord tissue (Wharton's jelly) optic neuropathy ophthalmology 2017 experimental therapy Poland 30.11
187 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2017 experimental therapy Poland 39.7
188 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 4.8
189 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 8.2
190 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 3.4
191 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 2.11
192 cord tissue (Wharton's jelly) delayed psychomotor development neurology 2017 experimental therapy Poland 7.9
193 cord tissue (Wharton's jelly) arthrogryposis multiplex congenita neurology 2017 experimental therapy Poland 3.5
194 cord tissue (Wharton's jelly) dystrophia myotonica neurology 2017 experimental therapy Poland 3.2
195 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 63.2
196 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2017 experimental therapy Poland 76.10
197 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /BMD neurology 2017 experimental therapy Poland 23.9
198 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 3.7
199 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 43.8
200 cord tissue (Wharton's jelly) optic neuropathy ophthalmology 2017 experimental therapy Poland 74.5
201 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 64.7
202 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 51.6
203 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 70.11
204 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 65.1
205 cord tissue (Wharton's jelly) encephalopathy neurology 2017 experimental therapy Poland 5.5
206 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 8.4
207 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 15.1
208 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 5.8
209 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 51.3
210 cord tissue (Wharton's jelly) muscular dystrophy neurology 2017 experimental therapy Poland 12.10
211 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 26.9
212 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 18.4
213 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 10.8
214 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 13.1
215 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 7.9
216 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 5.5
217 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 3.7
218 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 3.5
219 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 5.1
220 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 3.4
221 cord tissue (Wharton's jelly) Devic’s disease neurology 2017 experimental therapy Poland 45.2
222 cord tissue (Wharton's jelly) limb-girdle muscular dystrophy neurology 2017 experimental therapy Poland 31.3
223 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 6.10
224 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 5.3
225 cord tissue (Wharton's jelly) epilepsia, autism neurology 2017 experimental therapy Poland 6.0
226 cord tissue (Wharton's jelly) myopathy of congenital fiber type disproportion; damage to the central nervous system neurology 2017 experimental therapy Poland 2.2
227 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 2.7
228 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 68.1
229 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 59.3
230 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 49.1
231 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 60.1
232 cord tissue (Wharton's jelly) global developmental delay neurology 2017 experimental therapy Poland 7.11
233 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 2.8
234 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 4.11
235 cord tissue (Wharton's jelly) muscular dystrophy neurology 2017 experimental therapy Poland 10.8
236 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 56.7
237 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2017 experimental therapy Poland 38.0
238 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2017 experimental therapy Poland 25.2
239 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 58.7
240 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 3.2
241 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 4.7
242 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 4.8
243 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 63.0
244 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 62.9
245 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 57.9
246 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 59.11
247 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 46.5
248 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 53.9
249 cord tissue (Wharton's jelly) leukodystrophy neurology 2017 experimental therapy Poland 7.1
250 cord tissue (Wharton's jelly) atrophy of the optic nerves ophthalmology 2017 experimental therapy Poland 35.5
251 cord tissue (Wharton's jelly) epilepsia neurology 2017 experimental therapy Poland 16.4
252 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2017 experimental therapy Poland b/d
253 cord tissue (Wharton's jelly) tetraparesis orthopedics 2017 experimental therapy Poland 27.11
254 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2017 experimental therapy Poland 8.10
255 cord tissue (Wharton's jelly) epilepsia neurology 2017 experimental therapy Poland 9.11
256 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 4.11
257 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 15.3
258 cord tissue (Wharton's jelly) cerebral palsy; epilepsy neurology 2017 experimental therapy Poland 3.6
259 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 13.6
260 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 2.4
261 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 55.2
262 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2017 experimental therapy Poland 53.10
263 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2017 experimental therapy Poland b/d
264 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 3.3
265 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 2.3
266 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 4.2
267 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2017 experimental therapy Poland 27.3
268 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 3
269 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 4.9
270 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2017 experimental therapy Poland 47.6
271 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 65.4
272 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 2.3
273 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 54.6
274 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2017 experimental therapy Poland 77.5
275 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2017 experimental therapy Poland 30.6
276 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 78.6
277 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 10.11
278 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 44.5
279 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 60.8
280 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 32.2
281 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2016 experimental therapy Poland 64
282 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2016 experimental therapy Poland 62.5
283 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 18.4
284 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /DMD neurology 2016 experimental therapy Poland 48.8
285 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 10.3
286 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2016 experimental therapy Poland 35.3
287 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 53.7
288 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 12.2
289 cord tissue (Wharton's jelly) delayed psychomotor development neurology 2016 experimental therapy Poland 3.10
290 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2016 experimental therapy Poland 14
291 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2016 experimental therapy Poland 6
292 cord tissue (Wharton's jelly) gonarthrosis orthopedics 2016 experimental therapy Poland 65.8
293 cord tissue (Wharton's jelly) leukodystrophy neurology 2016 experimental therapy Poland 2.9
294 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 59.4
295 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 6
296 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 2.11
297 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 12.11
298 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 9.7
299 cord tissue (Wharton's jelly) atrophy of the optic nerves ophthalmology 2016 experimental therapy Poland 20.3
300 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2016 experimental therapy Poland 53
301 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 33.5
302 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 22.2
303 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 10.3
304 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 8.5
305 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 29.11
306 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 33.4
307 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 37.4
308 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 39.3
309 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 7.11
310 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 28
311 cord tissue (Wharton's jelly) gonarthrosis orthopedics 2016 experimental therapy Poland 69.6
312 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 33.11
313 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 20.7
314 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 24.5
315 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 25.6
316 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 8.5
317 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2016 experimental therapy Poland 39.10
318 cord tissue (Wharton's jelly) patella cartilage damage orthopedics 2016 experimental therapy Poland 60.10
319 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 6.9
320 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 44.8
321 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2016 experimental therapy Poland 25.4
322 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 10.10
323 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 63.2
324 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 54.11
325 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 53.9
326 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 46.9
327 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 58
328 cord tissue (Wharton's jelly) chronic graft versus host disease hematology 2016 experimental therapy Poland 19.2
329 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 55
330 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 58.1
331 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 61.7
332 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 52.6
333 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 59.11
334 cord tissue (Wharton's jelly) tetraparesis spastica orthopedics 2016 experimental therapy Poland 28.8
335 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 60.9
336 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2016 experimental therapy Poland 34.9
337 cord tissue (Wharton's jelly) gonarthrosis orthopedics 2016 experimental therapy Poland 69.3
338 cord tissue (Wharton's jelly) tetraparesis spastica orthopedics 2016 experimental therapy Poland 47.9
339 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 18.8
340 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 2.9
341 cord tissue (Wharton's jelly) traumatic brain injury neurology 2016 experimental therapy Poland 54.9
342 cord tissue (Wharton's jelly) epilepsia neurology 2016 experimental therapy Poland 19.5
343 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 59
344 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 66.9
345 cord tissue (Wharton's jelly) tetraparesis orthopedics 2016 experimental therapy Poland 27.9
346 cord tissue (Wharton's jelly) epilepsia neurology 2016 experimental therapy Poland 14.9
347 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 42.7
348 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2016 experimental therapy Poland 60.5
349 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 6.2
350 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 11.3
351 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 9.11
352 cord tissue (Wharton's jelly) gonarthrosis orthopedics 2016 experimental therapy Poland 49.8
353 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2016 experimental therapy Poland 69.9
354 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2016 experimental therapy Poland 69.1
355 cord tissue (Wharton's jelly) epilepsia neurology 2016 experimental therapy Poland 13.11
356 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 45.1
357 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 53.4
358 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 36.1
359 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 59, 1
360 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 66.2
361 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 49.7
362 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 55.1
363 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 46.1
364 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 72.4
365 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 54.3
366 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 56.1
367 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 61.8
368 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 64.7
369 cord tissue (Wharton's jelly) malformation syndrome neurology 2016 experimental therapy Poland 3.5
370 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 64.2
371 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 38
372 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 6.10
373 cord tissue (Wharton's jelly) encephalopathy neurology 2016 experimental therapy Poland 2.11
374 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 62.8
375 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 56.5
376 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 51.3
377 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 4.2
378 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 55.4
379 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 54.8
380 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 33.10
381 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 41.4
382 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 49.3
383 cord tissue (Wharton's jelly) choroideremia ophthalmology 2016 experimental therapy Poland 50.8
384 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 63.1
385 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 7.4
386 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 60.4
387 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 73.7
388 cord tissue (Wharton's jelly) leukodystrophy neurology 2016 experimental therapy Poland 2.11
389 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 61.6
390 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 48.3
391 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 32.7
392 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2016 experimental therapy Poland 3.11
393 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 61.11
394 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 45.8
395 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 61.4
396 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 79.2
397 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 72.6
398 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 48.4
399 cord tissue (Wharton's jelly) adrenoleukodystrophy neurology 2016 experimental therapy Poland 6.11
400 cord tissue (Wharton's jelly) adrenoleukodystrophy neurology 2016 experimental therapy Poland 9.7
401 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 54.2
402 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 50.9
403 cord tissue (Wharton's jelly) limb-girdle muscular dystrophy neurology 2016 experimental therapy Poland 22
404 cord tissue (Wharton's jelly) epilepsia neurology 2016 experimental therapy Poland 14.7
405 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 55.9
406 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 62.6
407 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 58.10
408 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 12.6
409 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 66.2
410 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 55.9
411 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 49.4
412 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 55.7
413 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 58.1
414 cord tissue (Wharton's jelly) spina bifida neurology 2016 experimental therapy Poland 4.8
415 cord tissue (Wharton's jelly) spina bifida neurology 2016 experimental therapy Poland 1.5
416 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 3
417 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 9.9
418 cord tissue (Wharton's jelly) global developmental delay neurology 2016 experimental therapy Poland 6.9
419 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 66.8
420 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 39.6
421 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 13.2
422 cord tissue (Wharton's jelly) developmental delay neurology 2016 experimental therapy Poland 7.4
423 cord tissue (Wharton's jelly) spina bifida neurology 2016 experimental therapy Poland 7.4
424 cord tissue (Wharton's jelly) optic neuropathy ophthalmology 2016 experimental therapy Poland 66
425 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 38.1
426 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 8.4
427 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 3
428 cord tissue (Wharton's jelly) optic neuropathy ophthalmology 2016 experimental therapy Poland 79.8
429 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2016 experimental therapy Poland 54.3
430 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /DMD neurology 2016 experimental therapy Poland 14.4
431 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 47.11
432 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 49.3
433 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 61.2
434 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 23.6
435 cord tissue (Wharton's jelly) age-related macular degeneration ophthalmology 2016 experimental therapy Poland 86.5
436 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 54.6
437 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 68.5
438 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 13.7
439 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 2.2
440 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 5.0
441 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 12.11
442 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 12.3
443 cord tissue (Wharton's jelly) spina bifida neurology 2016 experimental therapy Poland 1.3
444 cord tissue (Wharton's jelly) developmental delay neurology 2016 experimental therapy Poland 2.7
445 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2016 experimental therapy Poland 3.3
446 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2016 experimental therapy Poland 59.6
447 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2016 experimental therapy Poland 34.2
448 cord tissue (Wharton's jelly) muscular dystrophy neurology 2016 experimental therapy Poland 30.3
449 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2016 experimental therapy Poland 17.10
450 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 37.11
451 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 31.9
452 cord tissue (Wharton's jelly) ataxia hereditaria neurology 2016 experimental therapy Poland 69
453 cord tissue (Wharton's jelly) muscular dystrophy neurology 2016 experimental therapy Poland 31.9
454 cord tissue (Wharton's jelly) no data ophthalmology 2016 experimental therapy Poland 66.1
455 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 53.4
456 cord tissue (Wharton's jelly) patella cartilage damage orthopedics 2016 experimental therapy Poland 60.8
457 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 10.8
458 cord tissue (Wharton's jelly) encephalopathy neurology 2016 experimental therapy Poland 3
459 cord tissue (Wharton's jelly) spina bifida neurology 2016 experimental therapy Poland 2.11
460 cord tissue (Wharton's jelly) encephalopathy neurology 2016 experimental therapy Poland 4.3
461 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland no data
462 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 59.4
463 cord tissue (Wharton's jelly) atrophy of the optic nerves ophthalmology 2016 experimental therapy Poland 20.11
464 cord tissue (Wharton's jelly) patella cartilage damage orthopedics 2016 experimental therapy Poland 53
465 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 24.5
466 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /DMD neurology 2016 experimental therapy Poland 34, 7
467 cord tissue (Wharton's jelly) muscular dystrophy neurology 2016 experimental therapy Poland 32.3
468 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 65.9
469 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 52.7
470 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 71.5
471 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 60.7
472 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 1.10
473 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 7.6
474 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2016 experimental therapy Poland 1.10
475 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 29.7
476 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 68.5
477 cord tissue (Wharton's jelly) chronic graft versus host disease hematology 2016 experimental therapy Poland 8.12
478 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 44.5
479 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /DMD neurology 2016 experimental therapy Poland 9.2
480 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2016 experimental therapy Poland 24.5
481 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 66.7
482 cord tissue (Wharton's jelly) spina bifida neurology 2016 experimental therapy Poland 15.9
483 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 6.8
484 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 10.3
485 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 16.4
486 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 6
487 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2016 experimental therapy Poland 41.8
488 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 51.9
489 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 49.3
490 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 20.9
491 cord tissue (Wharton's jelly) fetal alcohol spectrum disorders neurology 2016 experimental therapy Poland 5.2
492 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 13.10
493 cord tissue (Wharton's jelly) tetraparesis spastica orthopedics 2016 experimental therapy Poland 58.4
494 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 68.2
495 cord tissue (Wharton's jelly) chondronecrosis femoral condyle orthopedics 2016 experimental therapy Poland 54.11
496 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 55.4
497 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 41.2
498 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 72.1
499 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 56.8
500 cord tissue (Wharton's jelly) spina bifida neurology 2016 experimental therapy Poland 2.11
501 cord tissue (Wharton's jelly) tetraparesis spastica orthopedics 2016 experimental therapy Poland 18
502 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 4.1
503 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 48.1
504 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 56.3
505 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 66.10
506 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland no data
507 cord tissue (Wharton's jelly) gangliosidosis t. 1 neurology 2016 experimental therapy Poland 1.4
508 cord tissue (Wharton's jelly) epilepsia neurology 2016 experimental therapy Poland 14.9
509 cord tissue (Wharton's jelly) epileptic encephalopathy neurology 2016 experimental therapy Poland 3.6
510 cord tissue (Wharton's jelly) polineuropathy neurology 2016 experimental therapy Poland 70.8
511 cord tissue (Wharton's jelly) diffuse cartilage damage left medial compartment of the knee orthopedics 2016 experimental therapy Poland 50.5
512 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2016 experimental therapy Poland 37.7
513 cord tissue (Wharton's jelly) myopia, hyperopia, astigmatism, abnormal refraction and accommodation, optic atrophy ophthalmology 2016 experimental therapy Poland 37.1
514 cord tissue (Wharton's jelly) optic neuropathy ophthalmology 2016 experimental therapy Poland 33.5
515 cord tissue (Wharton's jelly) epilepsia neurology 2016 experimental therapy Poland 16.2
516 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 3.7
517 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 17.9
518 cord tissue (Wharton's jelly) injuries to the spinal nerves neurology 2016 experimental therapy Poland 5.12
519 cord tissue (Wharton's jelly) cartilage damage orthopedics 2016 experimental therapy Poland 57.6
520 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /DMD neurology 2016 experimental therapy Poland 4.8
521 cord tissue (Wharton's jelly) muscular dystrophy neurology 2016 experimental therapy Poland 44.7
522 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /DMD neurology 2016 experimental therapy Poland 10
523 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 4.4
524 cord tissue (Wharton's jelly) spina bifida neurology 2016 experimental therapy Poland 4.9
525 cord tissue (Wharton's jelly) cerebellar syndrome neurology 2016 experimental therapy Poland 28.6
526 cord tissue (Wharton's jelly) neurodevelopmental disorders neurology 2016 experimental therapy Poland 4.5
527 cord tissue (Wharton's jelly) tetraparesis orthopedics 2016 experimental therapy Poland 27.2
528 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 61.2
529 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 44.8
530 cord tissue (Wharton's jelly) degeneration of the cartilage of the knee joint orthopedics 2016 experimental therapy Poland 54.3
531 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /BMD neurology 2016 experimental therapy Poland 19.2
532 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2016 experimental therapy Poland 15.0
533 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2016 experimental therapy Poland 31.11
534 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2016 experimental therapy Poland 33.4
535 cord tissue (Wharton's jelly) endometrial atrophy ginecology 2016 experimental therapy Poland 37.3
536 cord tissue (Wharton's jelly) endometrial atrophy ginecology 2016 experimental therapy Poland 39.1
537 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 38.4
538 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 44.5
539 cord tissue (Wharton's jelly) meniscus damage orthopedics 2016 experimental therapy Poland 35.5
540 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 60.8
541 cord tissue (Wharton's jelly) premature ovarian failure ginecology 2016 experimental therapy Poland 23.4
542 cord tissue (Wharton's jelly) premature ovarian failure ginecology 2016 experimental therapy Poland 34.9
543 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 55.5
544 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2015 experimental therapy Poland 1.4
545 cord tissue (Wharton's jelly) autism neurology 2015 experimental therapy Poland 5.4
546 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2015 experimental therapy Poland 23.2
547 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 61.6
548 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 61
549 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 56
550 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 51
551 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 65
552 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 60
553 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 52
554 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 3.8
555 cord tissue (Wharton's jelly) decerebration rigidity neurology 2015 experimental therapy Poland 9.6
556 cord tissue (Wharton's jelly) bilateral blindness ophthalmology 2015 experimental therapy Poland 36.10
557 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2015 experimental therapy Poland 11.12
558 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 7.1
559 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 15.8
560 cord tissue (Wharton's jelly) ceroid lipofuscinosis neurology 2015 experimental therapy Poland 5.1
561 cord tissue (Wharton's jelly) encephalopathy neurology 2015 experimental therapy Poland 14.5
562 cord tissue (Wharton's jelly) ceroid lipofuscinosis neurology 2015 experimental therapy Poland 7.10
563 cord tissue (Wharton's jelly) autism neurology 2015 experimental therapy Poland 3
564 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 7.1
565 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 13.1
566 cord tissue (Wharton's jelly) spina bifida neurology 2015 experimental therapy Poland 2.4
567 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 59.4
568 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 31.2
569 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 5.1
570 cord tissue (Wharton's jelly) autism neurology 2015 experimental therapy Poland 12.5
571 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 8.11
572 cord tissue (Wharton's jelly) delayed psychomotor development, deafness neurology 2015 experimental therapy Poland 3.3
573 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 61.5
574 cord tissue (Wharton's jelly) traumatic encephalopathy neurology 2015 experimental therapy Poland 20.11
575 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 18.8
576 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 2.7
577 cord tissue (Wharton's jelly) adrenoleukodystrophy; encephalopathy neurology 2015 experimental therapy Poland 23
578 cord tissue (Wharton's jelly) adrenoleukodystrophy neurology 2015 experimental therapy Poland 11.11
579 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 40
580 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 26.1
581 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 37.1
582 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 58
583 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2015 experimental therapy Poland 35.6
584 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2015 experimental therapy Poland 11.12
585 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2015 experimental therapy Poland 44.6
586 cord tissue (Wharton's jelly) optic neuropathy ophthalmology 2015 experimental therapy Poland 15.8
587 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 61.6
588 cord tissue (Wharton's jelly) gonarthrosis orthopedics 2015 experimental therapy Poland 66.2
589 cord tissue (Wharton's jelly) iatrogenic spinal cord injury neurology 2015 experimental therapy Poland 17.2
590 cord tissue (Wharton's jelly) optic neuropathy ophthalmology 2015 experimental therapy Poland 45.10
591 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 62
592 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2015 experimental therapy Poland 51.5
593 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 12.10
594 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 26.5
595 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 27
596 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 4.10
597 cord tissue (Wharton's jelly) autism neurology 2015 experimental therapy Poland 6.1
598 cord tissue (Wharton's jelly) autism neurology 2015 experimental therapy Poland 4.6
599 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 63.11
600 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 32.10
601 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 22
602 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2015 experimental therapy Poland 33.3
603 cord tissue (Wharton's jelly) delayed psychomotor development neurology 2015 experimental therapy Poland 3.6
604 cord tissue (Wharton's jelly) spina bifida neurology 2015 experimental therapy Poland 2
605 cord tissue (Wharton's jelly) cerebellar ataxia neurology 2015 experimental therapy Poland 18.7
606 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2015 experimental therapy Poland 24.3
607 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 67.6
608 cord tissue (Wharton's jelly) autism neurology 2015 experimental therapy Poland 5.6
609 cord tissue (Wharton's jelly) polineuropathy neurology 2015 experimental therapy Poland 74.2
610 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 37.6
611 cord tissue (Wharton's jelly) stroke neurology 2015 experimental therapy Poland 62.8
612 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 58.10
613 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2015 experimental therapy Poland 30.1
614 cord tissue (Wharton's jelly) chronic graft versus host disease hematology 2015 experimental therapy Poland 10
615 cord tissue (Wharton's jelly) severe developmental delay neurology 2015 experimental therapy Poland 1.1
616 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2015 experimental therapy Poland 26.2
617 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 46.2
618 cord tissue (Wharton's jelly) autism neurology 2015 experimental therapy Poland 8.7
619 cord tissue (Wharton's jelly) encephalopathy neurology 2015 experimental therapy Poland 8.12
620 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2015 experimental therapy Poland 6.6
621 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 48.7
622 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 21.4
623 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 9.9
624 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2015 experimental therapy Poland 13.4
625 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 61.3
626 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 54
627 cord tissue (Wharton's jelly) intracranial injury neurology 2015 experimental therapy Poland 24.3
628 cord tissue (Wharton's jelly) stroke neurology 2015 experimental therapy Poland 54.9
629 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 24.7
630 cord tissue (Wharton's jelly) gonarthrosis orthopedics 2015 experimental therapy Poland 65.9
631 cord tissue (Wharton's jelly) leukodystrophy neurology 2015 experimental therapy Poland 18.8
632 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 34.4
633 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 1.6
634 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 14.10
635 cord tissue (Wharton's jelly) anterior ischemic optic neuropathy ophthalmology 2015 experimental therapy Poland 54.10
636 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 16.9
637 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2015 experimental therapy Poland 34.5
638 cord tissue (Wharton's jelly) cerebellar ataxia neurology 2015 experimental therapy Poland 26.1
639 cord tissue (Wharton's jelly) encephalopathy neurology 2015 experimental therapy Poland 11.2
640 cord tissue (Wharton's jelly) adrenoleukodystrophy; encephalopathy neurology 2015 experimental therapy Poland 8.4
641 cord tissue (Wharton's jelly) neuropathy neurology 2014 experimental therapy Poland 23.6
642 cord tissue (Wharton's jelly) autism neurology 2014 experimental therapy Poland 12.6
643 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2014 experimental therapy Poland 6
644 cord tissue (Wharton's jelly) central motor coordination impairment after hypoxic ischaemia lesion at birth neurology 2014 experimental therapy Poland 2.1
645 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2014 experimental therapy Poland 60.10
646 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2014 experimental therapy Poland 24.1
647 cord tissue (Wharton's jelly) autism neurology 2014 experimental therapy Poland 8.3
648 cord tissue (Wharton's jelly) muscular dystrophy neurology 2014 experimental therapy Poland 6
649 cord tissue (Wharton's jelly) birth asphyxia; retinopathy neurology 2014 experimental therapy Poland 11.12
650 cord tissue (Wharton's jelly) cerebral palsy neurology 2014 experimental therapy Poland 4.10
651 cord tissue (Wharton's jelly) cerebral palsy neurology 2014 experimental therapy Poland 15.10
652 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2013 experimental therapy Poland 18.9
653 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2013 experimental therapy Poland 2.11
654 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2013 experimental therapy Poland 3.5
655 cord tissue (Wharton's jelly) acute myeloid leukemia hematology 2013 experimental therapy Poland 3.5
656 cord tissue (Wharton's jelly) chronic graft versus host disease hematology 2013 experimental therapy Poland 18.8
657 cord tissue (Wharton's jelly) chronic graft versus host disease hematology 2013 experimental therapy Poland 17.5
658 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2012 experimental therapy Poland 19.7
659 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2012 experimental therapy Poland 7.1
660 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2012 experimental therapy Poland 4.3
661 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2011 experimental therapy Poland 17.2
662 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy Poland 16
663 bone marrow  severe combined immunodeficiency hematology 2017 standard therapy Poland 1
664 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy Poland 6
665 bone marrow chronic granulomatous disease hematology 2017 standard therapy Poland 2
666 bone marrow chronic granulomatous disease hematology 2017 standard therapy Poland 4
667 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Germany 76
668 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Turkey 22
669 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Germany 65
670 bone marrow myelodysplastic syndrome hematology 2017 standard therapy Italy 60
671 bone marrow myelodysplastic syndrome hematology 2017 standard therapy USA 61
672 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy Russia 30
673 bone marrow leukemia hematology 2017 standard therapy USA 40
674 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy United Kingdom 10
675 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy Hungary 14
676 bone marrow severe combined immunodeficiency hematology 2017 standard therapy Turkey 6
677 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Italy 55
678 bone marrow acute myelogenous leukemia hematology 2017 standard therapy USA 67
679 bone marrow  severe combined immunodeficiency hematology 2017 standard therapy Lithuania 1
680 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Italy 13
681 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy Italy 38
682 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy United Kingdom 9
683 bone marrow  severe combined immunodeficiency hematology 2017 standard therapy Canada 1
684 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Russia 59
685 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy USA 21
686 bone marrow  severe combined immunodeficiency hematology 2017 standard therapy Turkey 2
687 bone marrow hyper IgM syndrome hematology 2017 standard therapy Finland 2
688 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy Austria 3
689 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Russia 1
690 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Italy 59
691 bone marrow acute myelogenous leukemia hematology 2017 standard therapy USA 57
692 bone marrow pure red cell aplasia hematology 2017 standard therapy USA 5
693 bone marrow thalassemia major hematology 2017 standard therapy Turkey 11
694 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Italy 10
695 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Czech Republic 68
696 bone marrow acute myelogenous leukemia hematology 2017 standard therapy USA 60
697 bone marrow Fanconi anaemia hematology 2017 standard therapy Russia 10
698 bone marrow acute myelogenous leukemia hematology 2017 standard therapy USA 10
699 bone marrow acute myelogenous leukemia hematology 2017 standard therapy USA 17
700 bone marrow acute myelogenous leukemia hematology 2017 standard therapy USA 51
701 bone marrow juvenile myelomonocytic leukemia hematology 2017 standard therapy Finland 1
702 bone marrow acute megakaryocytic leukemia hematology 2017 standard therapy Spain 2
703 bone marrow chronic myeloid leukemia hematology 2017 standard therapy USA 51
704 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Italy 56
705 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Russia 54
706 bone marrow acute myelogenous leukemia hematology 2017 standard therapy France 24
707 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy United Kingdom 8
708 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Italy 9
709 bone marrow no data hematology 2017 standard therapy France 32
710 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy Brazil 14
711 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy Italy 4
712 bone marrow Wiskott-Aldrich syndrome hematology 2017 standard therapy Iran 2
713 bone marrow T-cell leukemia/lymphoma hematology 2017 standard therapy Iran 18
714 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy Italy 7
715 bone marrow myeloma multiplex hematology 2017 standard therapy Canada 50
716 bone marrow OCID - othr combined immunodeficiency hematology 2017 standard therapy USA 11
717 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy Italy 2
718 bone marrow no data n/a 2016 standard therapy Poland 7
719 bone marrow severe combined immunodeficiency hematology 2016 standard therapy Romania 2
720 bone marrow osteopetrosis metabolic 2016 standard therapy Russia 6
721 bone marrow T-cell acute lymphoblastic leukemia hematology 2016 standard therapy Italy 4
722 bone marrow no data n/a 2016 standard therapy Italy 3
723 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Italy 64
724 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Italy 9
725 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Spain 55
726 bone marrow Fanconi anaemia hematology 2016 standard therapy Estonia 7
727 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Italy 6
728 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Italy 64
729 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Italy 14
730 bone marrow biphenotypic leukemia hematology 2016 standard therapy Brazil 27
731 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Germany 7
732 bone marrow osteopetrosis metabolic 2016 standard therapy Germany 1
733 bone marrow severe aplastic anaemia hematology 2016 standard therapy France 9
734 bone marrow Hurler syndrome metabolic 2016 standard therapy United Kingdom 2
735 bone marrow  severe combined immunodeficiency hematology 2016 standard therapy Turkey 4
736 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Canada 11
737 bone marrow myelofibrosis hematology 2016 standard therapy Germany 31
738 bone marrow DiGeorge syndrome hematology 2016 standard therapy Netherlands 24
739 bone marrow Hodgkin’s lymphoma hematology 2016 standard therapy Italy 17
740 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Belarus 12
741 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Belarus 18
742 bone marrow severe combined immunodeficiency hematology 2016 standard therapy Poland 7/12
743 bone marrow severe aplastic anaemia hematology 2016 standard therapy France 9
744 bone marrow severe aplastic anaemia / paroxymal nocturnal haemoglobinuria hematology 2016 standard therapy Poland 17
745 bone marrow myelodysplastic syndrome hematology 2016 standard therapy Hungary 1
746 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Italy 67
747 bone marrow myelodysplastic syndrome hematology 2016 standard therapy Spain 56
748 bone marrow Fanconi anaemia hematology 2016 standard therapy Netherlands 41
749 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy France 5
750 bone marrow acute myelogenous leukemia hematology 2016 standard therapy United Kingdom 29
751 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Belarus 25
752 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy New Zealand 1
753 bone marrow severe combined immunodeficiency hematology 2016 standard therapy Germany 12
754 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Poland 5
755 bone marrow no data n/a 2016 standard therapy Poland 33
756 bone marrow non-Hodgkin lymphoma hematology 2016 standard therapy Italy 46
757 bone marrow aplastic anaemia hematology 2016 standard therapy Austria 20
758 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Croatia 33
759 bone marrow myeloproliferative syndrome hematology 2016 standard therapy Poland 22
760 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Ireland 39
761 bone marrow Diamond-Balckfan anaemia hematology 2016 standard therapy Germany 2
762 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Czech Republic 9
763 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Belarus 15
764 bone marrow juvenile myelomonocytic leukemia hematology 2016 standard therapy Germany 3
765 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Finland 45
766 bone marrow anaemia hematology 2016 standard therapy Germany 16
767 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Germany 6
768 bone marrow anaemia hematology 2016 standard therapy Italy 5
769 bone marrow high-risk acute lymphoblastic leukemia hematology 2016 standard therapy Poland 18
770 peripheral blood białaczka prolimfocytowa z linii T hematology 2017 standard therapy Poland 63
771 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Poland 21
772 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 35
773 peripheral blood chronic granulomatous disease hematology 2017 standard therapy Poland 4
774 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Poland 38
775 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 38
776 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Poland 46
777 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 60
778 peripheral blood no data hematology 2017 standard therapy Poland 39
779 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 64
780 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy Poland 36
781 peripheral blood T-cell acute lymphoblastic leukemia hematology 2017 standard therapy Poland 7
782 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Poland 19
783 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 43
784 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 42
785 peripheral blood myeloproliferative neoplasms hematology 2017 standard therapy Poland 7
786 peripheral blood no data hematology 2017 standard therapy Poland 58
787 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 52
788 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 60
789 peripheral blood no data hematology 2017 standard therapy Poland 53
790 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy Poland 52
791 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Poland 30
792 peripheral blood severe aplastic anaemia hematology 2017 standard therapy Poland 27
793 peripheral blood severe aplastic anaemia hematology 2017 standard therapy Poland 32
794 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Poland 60
795 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Poland 43
796 peripheral blood severe aplastic anaemia hematology 2017 standard therapy Poland 14
797 peripheral blood Niemann–Pick disease hematology 2017 standard therapy Poland 2
798 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Poland 3
799 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 54
800 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Poland 3
801 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Poland 56
802 peripheral blood chronic lymphocytic leukemia hematology 2017 standard therapy Poland 47
803 peripheral blood myeloproliferative neoplasms hematology 2017 standard therapy Poland 7
804 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 52
805 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Poland 59
806 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 62
807 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Poland 59
808 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 53
809 peripheral blood Hurler syndrome hematology 2017 standard therapy United Kingdom 2
810 peripheral blood myeloma multiplex hematology 2017 standard therapy Germany 44
811 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy USA 24
812 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy United Kingdom 51
813 peripheral blood chronic myeloproliferative neoplasm blast crisis hematology 2017 standard therapy Germany 29
814 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy France 68
815 peripheral blood chronic myeloid leukemia hematology 2017 standard therapy Turkey 29
816 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Iran 17
817 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy USA 63
818 peripheral blood Common variable immunodeficiency, relapsed hemophagocytic syndrome hematology 2017 standard therapy Germany 44
819 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy France 65
820 peripheral blood myelofibrosis hematology 2017 standard therapy Spain 63
821 peripheral blood diffuse large B-cell lymphoma hematology 2017 standard therapy Germany 61
822 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 56
823 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Italy 48
824 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Austria 54
825 peripheral blood myelofibrosis hematology 2017 standard therapy Denmark 63
826 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Hungary 47
827 peripheral blood no data n/a 2017 standard therapy France 39
828 peripheral blood Langerhans Lymphohistiocytosis hematology 2017 standard therapy Czech Republic 2
829 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 75
830 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Slovakia 64
831 peripheral blood chronic lymphocytic leukemia hematology 2017 standard therapy Belgium 57
832 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Russia 32
833 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy USA 53
834 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 47
835 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy France 43
836 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Italy 48
837 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy France 56
838 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy Italy 47
839 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Spain 20
840 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Croatia 64
841 peripheral blood myelofibrosis hematology 2017 standard therapy Germany 66
842 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 44
843 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 53
844 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Netherlands 66
845 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Netherlands 75
846 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Italy 61
847 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Sweden 63
848 peripheral blood myeloma multiplex hematology 2017 standard therapy Germany 56
849 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Lithuania 59
850 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Italy 45
851 peripheral blood hemophagocytosis hematology 2017 standard therapy USA 52
852 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Brazil 12
853 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy Norway 57
854 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Belgium 19
855 peripheral blood chronic lymphocytic leukemia hematology 2017 standard therapy USA 45
856 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy USA 65
857 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 64
858 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Belgium 71
859 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Turkey 46
860 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Belgium 55
861 peripheral blood aplastic anaemia hematology 2017 standard therapy United Kingdom 23
862 peripheral blood myelofibrosis hematology 2017 standard therapy USA 62
863 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Germany 50
864 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Canada 57
865 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy Italy 58
866 peripheral blood chronic myelomonocytic leukaemia hematology 2017 standard therapy Germany 54
867 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Italy 32
868 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy France 75
869 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy USA 42
870 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 63
871 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Australia 60
872 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 53
873 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Germany 67
874 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy USA 33
875 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy Germany 56
876 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 65
877 peripheral blood B-cell Chronic lymphoblastic leukemia hematology 2017 standard therapy Germany 48
878 peripheral blood osteopetrosis hematology 2017 standard therapy Israel 3
879 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy France 56
880 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Italy 55
881 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Canada 56
882 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Lithuania 65
883 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Switzerland 75
884 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 69
885 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 51
886 peripheral blood T-cell acute lymphoblastic leukemia hematology 2017 standard therapy Australia 30
887 peripheral blood chronic lymphocytic leukemia hematology 2017 standard therapy Estonia 67
888 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 70
889 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Belgium 34
890 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 68
891 peripheral blood myelofibrosis hematology 2017 standard therapy United Kingdom 55
892 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Canada 67
893 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 67
894 peripheral blood β - Thalassemia Major hematology 2017 standard therapy India 4
895 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Czech Republic 48
896 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 55
897 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Czech Republic 62
898 peripheral blood acute myelogenous leukemia with myelodysplastic syndrome hematology 2017 standard therapy Germany 64
899 peripheral blood follicular CA hematology 2017 standard therapy South Africa 42
900 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Canada 63
901 peripheral blood chronic lymphocytic leukemia hematology 2017 standard therapy USA 65
902 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy USA 35
903 peripheral blood other myleofibrosis hematology 2017 standard therapy USA 71
904 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 64
905 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 69
906 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Italy 39
907 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 54
908 peripheral blood prolymphocytic leukemia hematology 2017 standard therapy Belgium 38
909 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy France 65
910 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy USA 23
911 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Slovakia 54
912 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Finland 46
913 peripheral blood myelofibrosis hematology 2017 standard therapy Germany 29
914 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Germany 63
915 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Czech Republic 12
916 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 29
917 peripheral blood no data hematology 2017 standard therapy Germany 65
918 peripheral blood no data hematology 2017 standard therapy Russia 36
919 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Turkey 58
920 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Turkey 54
921 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Netherlands 51
922 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 60
923 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Germany 49
924 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Hungary 32
925 peripheral blood myelofibrosis hematology 2017 standard therapy USA 62
926 peripheral blood no data hematology 2017 standard therapy Kanada 32
927 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy France 63
928 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy France 63
929 peripheral blood primary Immunodeficiency hematology 2017 standard therapy Russia 4
930 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy France 39
931 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy USA 62
932 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 65
933 peripheral blood chronic myelomonocytic leukaemia hematology 2017 standard therapy USA 58
934 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Italy 67
935 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 58
936 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Netherlands 51
937 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 69
938 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Switzerland 67
939 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy USA 68
940 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Amsterdam 69
941 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Israel 11
942 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Canada 4
943 peripheral blood T-cell acute lymphoblastic leukemia hematology 2017 standard therapy Australia 25
944 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Canada 55
945 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 68
946 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 76
947 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Canada 41
948 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Russia 49
949 peripheral blood myelofibrosis hematology 2017 standard therapy USA 62
950 peripheral blood primary Immunodeficiency hematology 2017 standard therapy Russia 2
951 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 65
952 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 51
953 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 35
954 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Belgium 70
955 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Germany 64
956 peripheral blood chronic myeloid leukemia hematology 2017 standard therapy USA 74
957 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 57
958 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 31
959 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Italy 64
960 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 60
961 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 49
962 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 53
963 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 22
964 peripheral blood B-cell Acute lymphoblastic leukemia hematology 2017 standard therapy Germany 44
965 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Lithuania 53
966 peripheral blood other malignancy hematology 2017 standard therapy France 59
967 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Italy 57
968 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Russia 54
969 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 61
970 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Hungary 40
971 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy Netherlands 53
972 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Finland 58
973 peripheral blood chronic myelomonocytic leukaemia hematology 2017 standard therapy United Kingdom 51
974 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 68
975 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 62
976 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Canada 46
977 peripheral blood primary myelofibrosis hematology 2017 standard therapy Germany 29
978 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 62
979 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 59
980 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 63
981 peripheral blood chronic myelomonocytic leukaemia hematology 2017 standard therapy Italy 61
982 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 53
983 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Italy 16
984 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy USA 17
985 peripheral blood T-cell acute lymphoblastic leukemia hematology 2017 standard therapy Greece 28
986 peripheral blood B-cell Acute lymphoblastic leukemia hematology 2017 standard therapy Spain 28
987 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy France 36
988 peripheral blood myelofibrosis hematology 2017 standard therapy Netherlands 72
989 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Belgium 69
990 peripheral blood chronic lymphocytic leukemia hematology 2017 standard therapy USA 51
991 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy Norway 56
992 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Australia 43
993 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 63
994 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 57
995 peripheral blood chronic lymphocytic leukemia hematology 2017 standard therapy Germany 7
996 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 40
997 peripheral blood myelodysplastic syndrome - RAEB hematology 2016 standard therapy Poland 56
998 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 18
999 peripheral blood adrenoleukodystrophy metabolic 2016 standard therapy Poland 1
1000 peripheral blood no data n/a 2016 standard therapy Poland 28
1001 peripheral blood Wiskott-Aldrich syndrome hematology 2016 standard therapy Poland 1
1002 peripheral blood chronic myelomonocytic leukemia, minimal residual disease hematology 2016 standard therapy Poland 50
1003 peripheral blood myeloma multiplex hematology 2016 standard therapy Poland 51
1004 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Poland 56
1005 peripheral blood no data n/a 2016 standard therapy Poland 43
1006 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 18
1007 peripheral blood Hodgkin’s lymphoma hematology 2016 standard therapy Poland 31
1008 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 54
1009 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 64
1010 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 42
1011 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy United Kingdom 58
1012 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Austria 60
1013 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Australia 62
1014 peripheral blood no data n/a 2016 standard therapy Czech Republic 45
1015 peripheral blood chronic lymphocytic leukemia hematology 2016 standard therapy Slovakia 52
1016 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy France 40
1017 peripheral blood no data n/a 2016 standard therapy Netherlands 70
1018 peripheral blood X-linked lymphoproliferative disease hematology 2016 standard therapy Russia 12
1019 peripheral blood chronic lymphocytic leukemia hematology 2016 standard therapy Sweden 61
1020 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 66
1021 peripheral blood no data n/a 2016 standard therapy Netherlands 69
1022 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Columbia 43
1023 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 64
1024 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Czech Republic 54
1025 peripheral blood T-cell leukemia/lymphoma hematology 2016 standard therapy Canada 31
1026 peripheral blood primary myelofibrosis hematology 2016 standard therapy Germany 50
1027 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Italy 31
1028 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Sweden 35
1029 peripheral blood no data n/a 2016 standard therapy Czech Republic 1
1030 peripheral blood no data n/a 2016 standard therapy Belgium 30
1031 peripheral blood no data n/a 2016 standard therapy Germany 71
1032 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 46
1033 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 29
1034 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Czech Republic 56
1035 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy France 32
1036 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Czech Republic 49
1037 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 50
1038 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 13
1039 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Slovakia 8
1040 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Belgium 46
1041 peripheral blood refractory anemia with excess blasts hematology 2016 standard therapy United Kingdom 62
1042 peripheral blood no data n/a 2016 standard therapy Sweden 58
1043 peripheral blood Hodgkin’s lymphoma hematology 2016 standard therapy Germany 32
1044 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 32
1045 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 66
1046 peripheral blood T Cell Lymphoma/ NOS - Not otherwise specified hematology 2016 standard therapy Germany 55
1047 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 43
1048 peripheral blood no data n/a 2016 standard therapy Czech Republic 59
1049 peripheral blood aplastic anaemia hematology 2016 standard therapy United Kingdom 23
1050 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 73
1051 peripheral blood myelofibrosis hematology 2016 standard therapy Israel 72
1052 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Australia 61
1053 peripheral blood primary myelofibrosis hematology 2016 standard therapy Germany 67
1054 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Ireland 47
1055 peripheral blood no data n/a 2016 standard therapy Germany 17
1056 peripheral blood no data n/a 2016 standard therapy France 59
1057 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 66
1058 peripheral blood chronic lymphocytic leukemia hematology 2016 standard therapy Germany 62
1059 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy France 47
1060 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy France 67
1061 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Lithuania 15
1062 peripheral blood Hodgkin’s lymphoma hematology 2016 standard therapy United Kingdom 18
1063 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Czech Republic 37
1064 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy France 24
1065 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Canada 13
1066 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Hungary 57
1067 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Belgium 56
1068 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy France 38
1069 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy France 52
1070 peripheral blood myeloma multiplex hematology 2016 standard therapy Germany 63
1071 peripheral blood Fanconi anaemia hematology 2016 standard therapy Estonia 7
1072 peripheral blood plasma cell disorder hematology 2016 standard therapy France 47
1073 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 35
1074 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 72
1075 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Spain 58
1076 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Estonia 62
1077 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Hungary 46
1078 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Hungary 20
1079 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Italy 51
1080 peripheral blood primary Immunodeficiency hematology 2016 standard therapy Russia 5
1081 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy United Kingdom 62
1082 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 69
1083 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Australia 51
1084 peripheral blood no data n/a 2016 standard therapy Netherlands 58
1085 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Spain 38
1086 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Lithuania 23
1087 peripheral blood chronic myeloid leukemia hematology 2016 standard therapy Germany 62
1088 peripheral blood Hodgkin’s lymphoma hematology 2016 standard therapy Germany 32
1089 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Germany 27
1090 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Poland 30
1091 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Turkey 55
1092 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Israel 63
1093 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Turkey 37
1094 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 66
1095 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Turkey 38
1096 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 65
1097 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 46
1098 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 18
1099 peripheral blood Hodgkin’s lymphoma hematology 2016 standard therapy Netherlands 38
1100 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Turkey 48
1101 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 61
1102 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy France 67
1103 peripheral blood no data n/a 2016 standard therapy Poland 55
1104 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy France 32
1105 peripheral blood T-cell acute lymphoblastic leukemia hematology 2016 standard therapy Germany 19
1106 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy United Kingdom 68
1107 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 59
1108 peripheral blood myelodysplastic syndrome - RCMD hematology 2016 standard therapy Czech Republic 32
1109 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Belgium 65
1110 peripheral blood myelofibrosis hematology 2016 standard therapy Netherlands 66
1111 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Switzerland 2/3
1112 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Israel 36
1113 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 66
1114 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Denmark 68
1115 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Spain 15
1116 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Italy 52
1117 peripheral blood chronic myelomonocytic leukaemia hematology 2016 standard therapy Finland 53
1118 peripheral blood no data n/a 2016 standard therapy Turkey 4
1119 peripheral blood leukemia hematology 2016 standard therapy Lithuania 53
1120 peripheral blood T-cell acute lymphoblastic leukemia hematology 2016 standard therapy Serbia 21
1121 peripheral blood myeloproliferative syndrome hematology 2016 standard therapy Poland 52
1122 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy France 63
1123 peripheral blood no data n/a 2016 standard therapy Poland 44
1124 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Czech Republic 60
1125 peripheral blood T-cell acute lymphoblastic leukemia hematology 2016 standard therapy Austria 41
1126 peripheral blood primary myelofibrosis hematology 2016 standard therapy Switzerland 67
1127 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy United Kingdom 20
1128 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Brazil 37
1129 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy France 60
1130 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 61
1131 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Turkey 51
1132 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy France 28
1133 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 65
1134 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Italy 53
1135 peripheral blood Lymphoblastic Lymphoma hematology 2016 standard therapy Italy 33
1136 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Slovakia 30
1137 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Belgium 9
1138 peripheral blood myeloma multiplex hematology 2016 standard therapy Poland 38
1139 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Poland 39
1140 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Austria 61
1141 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy New Zealand 59
1142 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Australia 62
1143 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 65
1144 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Portugal 41
1145 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy France 59
1146 peripheral blood SAA / Amyloidosis hematology 2016 standard therapy United Kingdom 45
1147 peripheral blood chronic myeloid leukemia hematology 2016 standard therapy Finland 46
1148 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 50
1149 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Italy 66
1150 peripheral blood non-Hodgkin lymphoma hematology 2016 standard therapy Russia 38
1151 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Poland 20
1152 peripheral blood myelofibrosis hematology 2016 standard therapy France 67
1153 peripheral blood B-cell Acute lymphoblastic leukemia hematology 2016 standard therapy Belgium 44
1154 peripheral blood non-Hodgkin lymphoma hematology 2016 standard therapy Poland 58
1155 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 72
1156 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy United Kingdom 68
1157 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 63
1158 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy France 56
1159 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 54
1160 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 24
1161 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Greece 9
1162 peripheral blood chronic myeloid leukemia hematology 2016 standard therapy Germany 40
1163 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 15
1164 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 37
1165 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Russia 44
1166 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 59
1167 peripheral blood non-Hodgkin lymphoma hematology 2016 standard therapy Russia 32
1168 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 62
1169 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 55
1170 peripheral blood composite lymphoma hematology 2016 standard therapy Germany 51
1171 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Italy 30
1172 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Germany 33
1173 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Italy 58
1174 peripheral blood high-risk acute lymphoblastic leukemia hematology 2016 standard therapy Poland 5
1175 peripheral blood acute myelogenous leukemia M2/M4 hematology 2016 standard therapy Germany 59
1176 peripheral blood non-Hodgkin lymphoma hematology 2016 standard therapy Netherlands 39
1177 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Italy 21
1178 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Spain 50
1179 peripheral blood plasma cell disorder hematology 2016 standard therapy France 54
1180 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy United Kingdom 47
1181 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Canada 47
1182 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 67
1183 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 62
1184 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Italy 63
1185 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 19
1186 peripheral blood T-cell-prolymphocytic leukemia hematology 2016 standard therapy United Kingdom 61
1187 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy USA 69
1188 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy France 35
1189 peripheral blood severe aplastic anaemia hematology 2016 standard therapy Russia 18
1190 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 66
{{$index+1}} {{item.source}} {{item.indication}} {{item.area}} {{item.year}} {{item.therapy}} {{item.country}} {{item.age | number}}

Last update: 30.09.2017